A clinical study to asses the effect of shunti in case of disease primary Dysmenorrhoea
Phase 3
Not yet recruiting
- Conditions
- Health Condition 1: N944- Primary dysmenorrhea
- Registration Number
- CTRI/2023/04/051380
- Lead Sponsor
- I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Subjects suffering form kashtaartava having classical signs and symptoms.
subjects willing and able to participate in the study
Exclusion Criteria
Subjects who are not willing for the clinical study.
Subjects suffering from acute systemic disorders.
subjects who belong to pitta prakriti will be excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method pain reduction <br/ ><br> <br/ ><br>Timepoint: 20days
- Secondary Outcome Measures
Name Time Method Reduction of pain during mensesTimepoint: 3 months
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms does Shunti utilize to alleviate primary dysmenorrhea symptoms?
How does Shunti's efficacy compare to standard-of-care treatments like NSAIDs for primary dysmenorrhea?
Are there specific biomarkers that correlate with Shunti's therapeutic response in primary dysmenorrhea patients?
What adverse events are associated with Shunti use in primary dysmenorrhea clinical trials?
What are the potential combination therapies involving Shunti for enhanced primary dysmenorrhea management?